Effects of benzo(e)pyrene and benzo(a)pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer: A comparative approach

Toxicology in Vitro

Volumn 21, Issue 5, 2007, Pages 827-834

  Sugihara, Narumi ^a   Toyama, Kumiko ^a   Okamoto, Tastuaki ^a   Kadowaki, Masaaki ^a   Terao, Kazumi ^a   Furuno, Koji ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Benzo(a)pyrene; Benzo(e)pyrene; Caco 2; MDR; P glycoprotein; Rhodamine 123

Indexed keywords

BENZO[A]PYRENE; BENZO[E]PYRENE; GLUTATHIONE; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123;

ARTICLE; CELL STRAIN CACO 2; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BENZO(A)PYRENE; BENZOPYRENES; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; CACO-2 CELLS; CARCINOGENS; CELL SURVIVAL; DNA DAMAGE; GLUTATHIONE; HUMANS; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; P-GLYCOPROTEIN; POLYCYCLIC HYDROCARBONS, AROMATIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINE 123; RNA, MESSENGER;

EID: 34247121977     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.02.005     Document Type: Article

References (41)

1. Abolhoda A., Wilson A.E., Ross H., Danenberg P.V., Burt M., and Scotto K.W. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin. Cancer Res. 5 (1999) 3346-3348
2. Arboix M., Paz O.G., Colombo T., and Dtncalci M. Multidrug resistance - reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis. J. Pharmacol. Exp. Ther. 281 (1997) 1226-1230
3. Arora A., Seth K., Kalra N., and Shukla T. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Toxicol. Appl. Pharmacol. 202 (2005) 237-243
4. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 140-141 (2003) 133-143
5. Buening M.K., Levin W., Wood A.W., Chang R.L., Lehr R.E., Taylor C.W., Yagi H., Jerina D.M., and Conney A.H. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice. Cancer Res. 40 (1980) 203-206
6. Buesen R., Mock M., Seidel A., Jacob J., and Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 183 (2002) 168-178
7. Buesen R., Mock M., Nau H., Seidel A., Jacob J., and Lampen A. Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites. Chem-Biol. Interact. 142 (2003) 201-221
8. Deng L., Lin-Lee Y.C., Claret F.X., and Kuo M.T. 2-Acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J. Biol. Chem. 276 (2001) 413-420
9. Fardel O., Lecureur V., Corlu A., and Guillouzo A. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem. Pharmacol. 51 (1996) 1427-1436
10. Felix R., and Barrand M.A. P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J. Neurochem. 80 (2002) 64-72
11. Fromm M.F. Importance of P-glycoprotein for drug disposition in humans. Eur. J. Clin. Invest. 33 (2003) 6-9
12. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276 (2001) 14581-14587
13. Hirsch-Ernst K.I., Kietzmann T., Ziemann C., Jungermann K., and Kahl G.F. Physiological oxygen tension modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures. Biochem. J. 350 (2000) 443-451
14. Hissin P.M., and Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74 (1976) 214-226
15. Huang Z.H., Murakami T., Okochi A., Yumoto R., Nagai J., and Takano M. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol. 406 (2000) 453-460
16. Jacob J., Schmoldt A., and Grimmer G. Benzo[e]pyrene metabolism in rat liver microsomes: dependence of the metabolite profile on the pretreatment of rats with various monooxygenase inducers. Carcinogenesis 4 (1983) 905-910
17. Jolles B., Demerseman P., Chalvet O., Strapelias H., Herning T., Royer R., and Duquesne M. Reactivity with DNA of three pyrenofuran analogues of benzo(a)pyrene and benzo(e)pyrene. Nucleic Acids Res. 15 (1987) 9487-9497
18. Lechapt-Zalcman E., Hurbain I., Lacave R., Commo F., Urban T., Antoine M., Milleron B., and Bernudin J.F. MDR1-Pgp 170 expression in human bronchus. Eur. Respir. J. 10 (1997) 1837-1843
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Mathieu M.C., Lapierre I., Brault K., and Raymond M. Aromatic hydrocarbon receptor (AhR)-AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J. Biol. Chem. 276 (2001) 4819-4827
21. Mitsunaga Y., Takanaga H., Matsuo H., Naito M., Tsuruo T., Ohtani H., and Sawada Y. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur. J. Pharmacol. 395 (2000) 193-201
22. Mossman T.J. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immuno. Methods 65 (1983) 55-63
23. Niemi M., Backman J.T., Fromm M.F., Neuvonen P.J., and Kivisto K.T. Pharmacokinetic interactions with rifampicin: clinical relevance 42 (2003) 819-850
24. Pei X.H., Nakanishi Y., Takayama K., Bai F., and Hara N. Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor κB activity. J. Biol. Chem. 274 (1999) 35240-35246
25. Ramesh A., Walker S.A., Hood D.B., Guillen M.D., Schneider H., and Weyand E.H. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int. J. Toxicol. 23 (2004) 301-333
26. Rosenberg D.W., and Leff T. Regulation of cytochrome P450 in cultured human colonic cells. Arch. Biochem. Biophys. 300 (1993) 186-192
27. Schuetz E.G., Yasuda K., Arimori K., and Schuetz J.D. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene. Arch. Biochem. Biophys. 350 (1998) 340-347
28. Schwab M., Eichelbaum M., and Fromm M.F. Genetic polymorphisms of the human MDR1 drug transporter. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 285-307
29. Setsukinai K., Urano Y., Kakinuma K., Majima H.J., and Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 278 (2003) 3170-3175
30. Shou M., Korzekwa K.R., Crespi C.L., Gonzalez F.J., and Gelboin H.V. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and nemzo[a]pyrene trans-7,8-dihydrodiol. M. Carcinog. 10 (1994) 159-168
31. Slaga T.J., Gleason G.L., Mills G., Ewald L., Fu P.P., Lee H.M., and Harvey R.G. Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. Cancer Res. 40 (1980) 1981-1984
32. Smolarek T.A., and Baird W.M. Benzo[e]pyrene-induced alterations in the binding of benzo[a]pyrene to DNA in hamster embryo cell cultures. Carcinogenesis 5 (1984) 1065-1069
33. Sugihara N., Toyama K., Michihara A., Akasaki K., Tsuji H., and Furuno K. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer. Toxicology 223 (2006) 156-165
34. Tang F., Ouyang H., Yang J.Z., and Borchardt R.T. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. J. Pharm. Sci. 93 (2004) 1185-11941
35. Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther. Drug Monit. 22 (2000) 137-140
36. Terao T., Hisanaga E., Sai Y., Tamai I., and Tsuji A. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm. Pharmacol. 48 (1996) 1083-1089
37. Thakker D.R., Levin W., Buening M., Yagi H., Lehr R.E., Wood A.W., Conney A.H., and Jerina D.M. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region. Cancer Res. 41 (1981) 1389-1396
38. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., and Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84 (1987) 7735-7738
39. Wood A.W., Levin W., Thakker D.R., Yagi H., Chang R.L., Ryan D.E., Thomas P.E., Dansette P.M., Whittaker N., Turujman S., Lehr R.E., Kumar S., Jerina D.M., and Conney A.H. Biological activity of benzo[e]pyrene. J. Biol. Chem. 254 (1979) 4408-4415
40. Wood A.W., Chang R.L., Huang M.T., Levin W., Lehr R.E., Kumar S., Thakker D.R., Yagi H., Jerina D.M., and Conney A.H. Mutagenicity of benzo(e)pyrene and triphenylene tetrahydroepoxides and diol-epoxides in bacterial and mammalian cells. Cancer Res. 40 (1980) 1985-1989
41. Yan Z., Subbaramaiah K., Camilli T., Zhang F., Tanabe T., McCaffrey T.A., Dannenberg A.J., and Weksler B.B. Benzo[a]pyrene induced the transcription of cyclooxygenase-2 in vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 4949-4955